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Purpose: Drug microparticles may be microencapsulated with water-insoluble polymers to 
obtain controlled release, which may be further determined by the particle distribution. The 
purpose of this study was to determine the drug release parameters needed for the 
theoretical prediction of the release profiles of single aspirin crystals and their microcapsules. 
Method:  Four single crystals of aspirin of varied weight and orthorhombic in shape or their 
microcapsules also of varied weights were randomly selected for the study. The 
microcapsules were walled with an acrylatemethacrylate copolymer (wall thickness, 11 ì m).  
The following parameters were evaluated: the order of release, the dissolution rate constant, 
k (crystals), the diffusion coefficient, D (microcapsules), the maximum release m∞ and time to 
attain it t∞. These parameters were in turn used to simulate the release profiles of hypothetical 
single particles of a wide range size distribution, 0.3 – 1.4 mm at 0.1mm intervals.  
Results: The empirical single crystals exhibited an initial zero order (93%; dissolution 
constant = 4.4 min-1) followed by a first order release (6%; dissolution constant = 0.38 min-1). 
Maximum release from each of the crystals was 99% of the initial particle weight; thus m∞ was 
a constant fraction of the initial particle weight. A zero order release consistent with a Fickian 
diffusion model was displayed by the single microcapsules (diffusion coefficient, 5.4x10-4 
mm2min-1). At same particle weight the release parameters m∞, t∞, and the slopes of the rate 
order plots compared favourably with the theoretical data. 
Conclusion: The study indicates that the empirical release data on a few single particles can 
be used to predict the release profiles of single particles of a wide range of size distribution. 
This finding may be exploited in the prediction of drug release from polydisperse systems.   
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Introduction 
 
The selection by trial and error of 
formulations that will give optimal 
performance is not only tedious but 
expensive, hence simulation has become 
important in optimisation in formulation 
studies. Such simulations involve the 
development of mathematical models1-4 or 
use of well known (i.e. previously 
determined) constants3 which have been 
referred to here as the drug release 
parameters.  Drug delivery systems are of 
different designs. Perhaps the most common 
design is that whereby the drug particles 
acting as core material are coated with a 
polymer as wall material4-6.  The purpose of 
such a device is to control either the rate 
and/or the onset of the release.  In practical 
situations, such a system is polydisperse as 
the component individual particles are 
distributed either with respect to particle size, 
shape, wall material used in the 
microencapsulation, and/or the thickness of 
the wall material.  Various studies5-8 showed 
that drug release from such polydisperse 
systems follow a first order kinetic. 
 
However, Hoffmann and co-workers3 
investigated the release profiles from single 
drug particles, which were microencap-
sulated with different polymers as wall 
materials and compared the individual 
release profiles with those of the ensembles 
of the microcapsules.  Whereas the single 
microcapsules displayed zero order (Fickian 
diffusion) kinetics the ensembles displayed a 
first order release profile. The summation of 
the individual releases at each time scale for 
the various time intervals gave a cumulative 
curve of the first order profile similar to the 
empirical release profile of the ensembles.  
The difference in the release kinetics (single 
particles compared with their ensembles) 
was attributed to the observation that the 
single particles were inhomogenously 
distributed with regards to the release 
parameters, m∞, which is the maximum 
release or payload and t∞, the time to attain 
it. The important conclusion, which is the 
basis of the present study, is that under sink 
conditions the release profile of a 
polydisperse system can be simulated by a 
simple summation of the individual releases 
from single particles. 
 
In the previous study3 up to 20 to 30 single 
particles were used to determine the 
individual releases from which data the 
cumulative release curve for the ensembles 
were simulated. The application of this 
finding is that the particle distribution can be 
predetermined to give an optimal release 
profile for a polydisperse system.  However 
the procedure involving measurement of 
drug release data for several single particles 
is tedious.  Hence, in the present study a few 
(four) representative particles were used to 
determine the release parameters, which 
could in turn be used in the simulation of 
drug release from several single particles. 
Such theoretical data on single particles can 
in turn be used to simulate releases from 
ensembles of particles of an accidental or a 
predetermined distribution. In this first part of 
the study, we present how the empirically 
determined parameters were used to 
simulate the release profiles of hypothetical 
single particles. The validity of the models 
used in the simulation was tested by 
matching the values of the expected results 
with the observed results. 
 
Materials and Methods 
 
Aspirin crystals (Synopharm Ltd, Germany) 
were selected for the study primarily 
because they are amenable to microen-
capsulation by spray coating procedure. A 
water-insoluble copolymer, an acrylate-
methacrylate, Eudragit RS 100 (Rohm 
Pharma, Darmstadt, Germany), was used as 
the wall material during microencapsulation 
of the aspirin crystals. Acetone (analar 
grade) was used as the coating solvent. The 
particle size distribution of the aspirin 
crystals (as ascertained by electron 
microscopy) showed a range of 0.3 to 1.4 
mm.  The particles were mainly orthorhombic 
(about 95%) with a few cubic particles (about 
5%), also ascertained by electron 
microscopy. 
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Figure  1: Cross section of microcapsule for 
determination of film thickness (x1800)   
Microencapsulation technique  
 
The crystals were spray-coated with a 10% 
w/v organic solution of the polymer in a 
Wurster column. The air inlet and outlet 
temperatures were 20o C. The coating was 
applied in 3 aliquots of 5 ml each allowing 5 
min drying between each application and 
drying for a further 30 min after the last 
application.   
 
Determination of film coat thickness 
 
A cross section of the microcapsule was 
made and placed on the specimen stub 
assembly. A thin film of gold was applied by 
vacuum coating using Sputter apparatus 
(Balzers Union Ltd, type SCD 040). The 
specimens were examined with an electron 
scanning microscope, Stereoscan S4 
TL10701-0M-96118 (Cambridge, England). 
Photomicrographs of the specimens were 
taken at x1800 magnification (Figure 1). Film 
thickness was determined at different points 
on the micrograph with the aid of electron 
markers or scale bar as indicated on the 
micrograph. The determination was carried 






Drug release experiments 
 
Two sets of the particles were studied 
including the crystals and their micro-
capsules produced with the polymer 
acrylate-methacrylate as wall material.  From 
each set, four representative particles were 
randomly picked, examined microscopically 
for shape and weighed with a sensitive 
electronic balance. The particle was placed 
in a cuvette containing 1 ml of leaching fluid 
(i.e., water maintained at 37o C). The cuvette 
was mounted on a shaker water bath 
oscillating at 50 rev.min−1. At predetermined 
intervals 3 min (for the crystals) and 30 min 
(for the microcapsules) the cuvette was 
placed in a spectrophotometer, Hitachi U-
1100 (Hitachi Ltd, Tokyo, Japan) to 
determine the concentration of aspirin 
leached. The determination was carried out 
at 267 nm and in triplicates. Invariably the 
particle was floating in the cuvette above the 
incident ray; its presence in the cuvette 
therefore did not interfere with the analysis. 
All the particles used in each experiment 
were orthorhombic; they were therefore 
distributed with regard to particle weight only 
in each set. 
 
Determination of the drug release 
parameters 
 
Release kinetics: The release data were 
analysed on the basis of zero or first order 
kinetic since these are the commonly 
reported kinetics of release from drug micro 
particles3-7. The release was considered to 
have followed a particular mechanism if the 
linear correlation for the plot was ≥ 0.95. A 
double phase kinetic of an initial zero order 
followed by a first order release was also 
considered. 
 
The dissolution rate constant: The 
parameter is applicable to uncoated particles 
only (e.g., the crystals). The zero order 
release constant (k0) was calculated from the 
slope of the plot of amount released (m) 
versus time, t, thus9: 
 
m  =   Sk0t                (1) 
 
where S is the particle surface area.  At the 
end of zero order release m = m1 and t = t1 
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(see Figure 2) hence equation (1) may be re-
written as: 
 
m1 = Sk0t1                            (2) 
 
which has a slope of m1/t1 = Sk0.  By 
determining m1 and t1 from the empirical 
data, the value of k0 was obtained.  The first 
order release constant (k1) was obtained 
from the slope of the first order equation9: 
 
        log(wt) = log(w0) – 0.43k1t        (3)  
 
where wt is the residual amount of drug in 
time, t, and w0 is the initial amount of drug at 
the beginning of the first order release. In the 
situations where the particle undergoes an 
initial zero order followed by a first order 
release (i.e., biphasic) as illustrated in Figure 
2, w0 = (m0 – m1) and wt at the point of 
maximal release = (m0 – m∞) and t = (t∞ – t1); 
where m1 is the amount released in time, t1 
at the beginning of the first order release 
which is also the end of the zero order 
release, and m∞ is the maximal release at t∞. 
Hence substituting these values in equation 
3, gives the expression: 
 
log(m0 – m∞) = log(m0 – m1) – 0.43k1(t∞ – t1)   (4) 


























− ∞                (6)                             
 
The plot of log w1 versus t gave a slope = – 
0.43k1 from which the value of k1 was 
obtained.  
 
The point for transition from zero to first 
order release (m1, t1): As noted earlier 
above, the parameter (m1) is the amount of 
drug released at the end of the zero order 
flux which is also the point of 
commencement of the first order flux. The 
ratio, m1/m0, is the fractional release at the 
transition point. The value of m1 was 
obtained empirically from the plot of m 
versus t. The interpolation of the linear 
portion to meet the curve portion gave an 
intercept, which was taken as m1 and the 













           0        t1                  t∞       t 
 
Figure 2: Model of drug release from the single 
crystal showing the zero order release up to t1 
followed by first order release between time t1 and 
t∞ (m1 is the amount released at the end of the 
zero order flux. m∞ is the maximum release). 
 
Maximum release (m∞) and the time to 
attain it (t∞): A model for a zero order 
release from single microcapsules is 
illustrated in Figure 3. The intercept between 
the linear portion and the plateau gave the 
point for maximum release m∞ and the t∞.  In 
the biphasic release profile (Figure 2) the 
intercept between the curve and the plateau 
gave the point for the maximum release m∞ 
and t∞.  The ratio, m∞/m0, is the maximum 
fractional release. 
 
Diffusion coefficient (D): This parameter 
relates to the microcapsules only whereby 
drug release occurs by membrane diffusion.  
The release profile will fit into the model in 
Figure 3.  The value of D, was obtained from 
the slope of the Fick’s equation10: 
 
m  = 
L
tDSCo
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where L is the membrane thickness and Co, 
the drug solubility which in the case of 













       0                t∞       t 
 
Figure 3: Model of drug release profile from a 
single microcapsule 
 
Theoretical estimation of particle surface 
area and weight 
 
Particle surface area or weight is determined 
by both its size and shape. Since the 
particles investigated were predominantly 
orthorhombic, the estimation was carried out 
for this particle shape only. The particle 
surface area, S, and its weight, m0, were 
derived from the particle size, d, and its 
shape (orthorhombic) to be 
 
       S   =  1.33d2            (8) 
       m0 =   0.08 x 1000 x d3 = 80d3  (9) 
 
where d is the longest distance between two 












Figure 4: An illustration of a typical hypothetical 
orthorhombic particle with dimensions as a, b and 
c; the particle size is d. 
 
Equations 8 and 9 were derived as follows:  
Consider a hypothetical orthorhombic 
particle (see Figure 4), which has 3 sides (a, 
b, c) corresponding to the width, length and 
height, respectively. In a model orthorhombic 
particle the width is half the length, but twice 
the height thus giving the dimensions in 
terms of a, to be: width =a, length =2a, and 
height = 0.5a. Most of the orthorhombic 
particles actually observed by scanning 

















Figure 5: Scanning Electron Micrograph of an 
orthorhombic crystal  (x 90) 
 
The diagonal of the base, x, is given by the 
Pythagoras Theorem to be:  
 
x2   =   a2+b2    =  a2+(2a)2   =   5a2    (8.1)  
                 
The particle size, d, is also given by the 
Pythagoras Theorem to be 
 
d2  =  x2+ c2  = 5a2 + (0.5a)2  =  5.25a2   (8.2) 
from where a2   =
25.5
2d
                 (8.3) 
or   a  =   
25.5
d
            (8.4)  
 
To calculate the surface area in terms of d, 
the area of the six surfaces were considered 
and expressed as  
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Substituting a for the values of b and c gives  
  
S  = 2 [ (ax2a) + (2a x 0.5a) + (0.5a x a) ]   (8.6) 
S   = 2 [ 2a2 + a2+ 0.5a2 ]  =7a2                        (8.7) 
From equation (8.3),  a2  = 
25.5
2d
         (8.8) 
Hence    S  =
25.5
7
 x d2     =1.33 d2           (8.9) 
 
The corresponding particle weight is given 
by the equation 9.4, which was derived as 
follows:  
 
Referring to Figure 4, the particle volume is 
given by  
 
v = a x b x c          (9.1) 
 
Substituting ‘a’ for the values of ‘b’ and ‘c’, 
will give the expression 
 
v =  a x 2a x 0.5a  = a3       (9.2) 
Since from equation (8.3) a2 = 
25.5
2d
  and 
hence  a = 
25.5
d
, the particle volume can 
be expressed in terms of particle size, d, by 






  = 
023.12
3d
  =0.08d3  (9.3)       
 
The particle weight is given by: 
 
w  =  0.08 d3 •           (9.4) 
 
where •  is  the particle dens ity. For the 
purpose of estimation, •  was taken as  1g/ml 
or 1mg.mm-3. When d is in mm and •  is  in 
mg.mm-3, the unit of weight is in mg. To 
convert to µg, the weight was multiplied by 
1000, which gave the expression in equation 
9. It follows from equations 8 and 9 that for a 
given particle size, the surface area or 
weight can be deduced and vice versa. The 
calculated values of surface area and 
weights for single crystals of different particle 
sizes are given in Table 1. 
Table 1: The calculated values of surface area 
and weights of hypothetical single crystals of 







Weight, ì g 
0.3 0.12 2.16 
0.4 0.21 5.32 
0.5 0.33 10.0 
0.6 0.48 17.28 
0.7 0.65 28.51 
0.8 0.85 40.96 
0.9 1.08 58.32 
1.0 1.33 80.0 
1.1 1.61 106.48 
1.2 1.92 138.24 
1.3 2.25 175.76 
1.4 2.61 219.52 
 
Simulation technique  
 
A computer programme (GW–BASIC) was 
used in the computation. Built into the 
programme were the equations for the 
calculation of particle surface area and 
weight, the relevant drug release kinetic, the 
time intervals for the release, 3 min in the 
case of the crystals and 30 min for 
microcapsules. Also included in the 
programme were the release parameters - 
m∞, t∞; m1 and t1, k0, and k1(crystals) m∞, t∞, D 
(microcapsules). The number of each 
particle size and/or membrane thickness 
were also taken into account in the 
computation. 
 
In the operation of the programme, the 
individual theoretical particle size and shape 
were entered into the computer and the 
sequence-particle weight, and the 
cumulative release at each predetermined 
time intervals were computed. The release is 
programmed to produce a maximum at the 
predetermined point (m∞, t∞), followed by a 
plateau. In the case of crystals only, the 
release was programmed to change from a 
zero to a first order computation at the 
predetermined point (m1, t1).  
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Validation of results 
 
To validate the models developed in the 
estimation, the empirical data were 
compared with those of the theoretical 
release data. The expected (theoretical) and 
the observed (empirical) results were 
compared by means of proportional 
difference [(T –E) / T] x 100%, (i.e., the % 
deviation) where T= theoretical and E = 
empirical result. The release parameters 
compared were the m1 t1, m• , and t• ,  slope of 
the zero and first order plots, for the crystals 
and for the microcapsules, m•  and t•  and the 
slopes of the zero order plot; these being the 
parameters that define the drug release 
profiles of the particles. The test was carried 
out for the four single particles of the crystals 
or the microcapsules. The prediction was 
considered valid if the standard deviation 
(SD) was within ±10% of the expected result. 
 
Results and Discussion 
 
Release characteristics of the empirical 
single crystals 
 
The release profile (m versus t) of each of 
the four single crystals is given in Figure 6. 
Crystals exhibited a biphasic (zero order 
followed by a first order) release profile. This 
release profile is consistent with the model in 
Figure 2. The correlation coefficients of the 
zero order and first order phases were 
generally ≥ 0.95 and fell below 0.70 when 
the data were plotted throughout the time 
course of the release either on the basis of 
zero order only or as first order only. Values 
of the parameters m∞, t∞; m1 and t1 obtained 
from the plots are presented in Table 2. The 
general trend was that the values of m1 or 
m∞ increased with increase in the initial 
weight of the particle.  Factors that will 
determine release profile from a single 
crystal will be the presence of a saturated 
solution on the surface of the particle on one 
hand and the surface area on the other 
hand9. The first factor (saturated film) was 
expected to lead to a zero order release and 





















39 39 9 39 9 1.0 1.0 5.26 NM 
87 80.04 12.94 87 18 0.92 1.0 3.43 0.368 
143 124 14.38 140 18 0.87 0.98 3.97 0.457 
235 220.9 18.4 235 18 0.94 1.0 4.78 0.314 
Mean ± SD     0.93±0.05 0.99±0.009 4.4±0.71 0.38±0.06 
























Figure 6: Profiles of drug release from empirical 
single crystals of different particle weights (µg)  
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Table 3: The theoretically estimated values of the drug release parameters m1, t1, m∞ and t∞ for 
hypothetical orthorhombic crystals of various sizes and weights 
Estimated values of the Parameters Particle size, 
mm 
Theoretical particle 










































































provide sink conditions which will prevail in 
the leaching fluid. Second factor (surface 
area) diminishes with time and at a critical 
point the release rate will depend on the 
residual particle surface area. These two 
factors explain the biphasic order of release 
from the crystals. 
 
Predicted values of m1, t1, m∞ and t∞ for the 
hypothetical single crystals 
 
The prediction of m, and m∞ values was 
based on the empirical data in Table 2 which 
shows that the ratio m1/m0 is a constant for 
the set of crystals with a mean value of 0.93 
± 0.05.  For a hypothetical crystal of particle 
weight, m0, m1 is given by: 
 
m1 = 0.93 m0                        (10) 
 
The corresponding t1 values were obtained 
by substituting the calculated values of m1, S 
and the empirical values of k0 into equation 
2. Also from Table 2, the ratio m∞/m0 is a 
constant for the set of crystals with a mean 
value of 0.99 ± 0.009.  For a hypothetical 
crystal of particle weight, m0 the m∞ will be 
given by: 
 
m∞ = 0.99 m0                   (11) 
 
Corresponding t∞ value was obtained by 
substituting the calculated values of m∞, t1, 
m1 and the empirical value of k1 into equation 
6. The calculated values of m1, t1, m∞ and t∞ 
for hypothetical particles of different particle 
sizes and weights are given in Table 3.  
These parameters define the release profiles 
for the single crystals as they predetermine 
the points that the release will change from a 
zero to first order profile and the point for the 
attainment of maximum release. 
 
Simulated release profile for the hypothetical 
single crystals 
 
The observed zero order and first order 
release constants were 4.4 min-1 and 0.38 
min-1 respectively.  Release profile for a 
given particle size was based on equation 1 
(zero order) and equation 3 (first order). The 
point of transition from zero order to first 
order flux (m1, t1) was predetermined as the 
calculated values of m1 and t1 for that 
particular particle size (see Table 3). The 
point of maximum release was also 
predetermined as the calculated value of m∞ 
and t∞ for that particular particle size. 
Theoretical release data thus generated are 
plotted in Figure 7 for orthorhombic particles 
of varying sizes (0.3 – 1.4 mm). Thus, from 
the empirical data on a few representative 
crystals, it was possible to simulate the 
release profiles of theoretical particles of a 
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wide range in size distribution. Values of the 
observed release parameters were 
compared with the expected results in Table 
4.  The standard deviations of the observed 
results were generally within + 10% of the 
expected result except in the case of the 
zero order slope where the standard 
deviation was up to + 15% (Table 5). This 
analysis shows that the predictions were 
accurate with a probability of over 85%. 
 
Drug release characteristics of the empirical 
single microcapsules 
 
Drug release from the single microcapsules 
followed a zero order profile (i.e., a Fickian 
diffusion model) as illustrated in Figure 3, 
which agrees with previously reported 
kinetics for single microcapsules3, 4. Actual 
releases are shown in Figure 8 where it can 
be seen that the releases were characterised 
by the parameters, m∞ and t∞. Values of 
these parameters are given in Table 6. The 
ratio, m∞/m0 (where m0   is initial core weight) 
was a constant with a mean value of 
0.47±0.04 for the set of microcapsules. The 
m∞ and t∞ however varied with particle 
weights. Diffusion coefficients calculated 
from the slopes of the plots in Figure 8 had a 
mean value of 0.54x10-3 mm.2min-1. 
 
The evidence for the zero order profile was 
that the correlation coefficient for the m-t 
plots (Figure 8) was >0.95. This zero order 
flux implies a constant concentration 
gradient across the wall throughout the time 
course of the leaching experiment. A 
saturated solution of the drug is expected 
inside the core so long as undissolved 
particle remains in the core; this together 
with sink conditions outside the core, will 
ensure a constant concentration gradient, 
hence the constant release kinetics. The 
maximum release was 47% of the initial core 



















































Figure 7: Theoretical release profile of 
hypothetical single crystals of various particle 
sizes (mm) Figure 8: Empirical release from the four 
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Table 4: The comparison of the drug release parameters for empirical and theoretical single crystals 
of same weight 
Slope 

















E T E T E T E T E T E T 
39 4.33 3.6 39 36 9 10 NM NM 39 38.6 9 15 
87 4.83 6.23 80 81 14.9 13 -0.158 -0.156 87 86.13 18 18 
143 7.78 8.87 124 133 16 15 -0.197 -0.167 140 141.56 18 21 
235 13.06 12.17 221 219 18 18 -0.135 -0.151 235 232.65 18 23.53 
NM, Not measurable; T = theoretical and E, the empirical result 
point where the solute concentration inside 
the core falls below the saturation point and 
the eventual concentration gradient is too 
low to produce any further measurable 
release.  
 
Theoretical release data for the single 
microcapsules 
 
From Table 6, the ratio, m∞/m0, was a 
constant (0.47). Therefore the m∞ for any 
given core weight can be predicted from the 
relationship: 
 
m∞ =  0.47 m0        (12 ) 
 
The corresponding t∞ values were estimated 
from the Fick’s diffusion law (equation 6). 
The calculated m∞ and t∞ values are 
presented in Table 7 for hypothetical 
microcapsules of varying core sizes and 
weights. By substituting the theoretical 
values of m∞, t∞ and the empirical value of 
diffusion coefficient (0.54x10-3 mm.2min-1) 
into equation 7 it was possible to construct 
the release profile for the single 
microcapsules at 30min intervals for up to 
the time for maximum release. The results 
are plotted in Figure 9. Main feature of the 
results is that both m∞, and t∞ increased with 
Table 5: The percentage deviation in the observed values of the release parameters from the 
expected results for the four single crystals 
Slope  






m∞ zero order                     first order    
39 -8.33 10 -1.04 -20.27 - 
87 1.23 -14.6 -1.01 22.47 1.28 
43 6.77 -6.67 1.10 12.29 -17.96 
235 -0.91 0 1.10 -7.31 -10.6 
SD ± 4.31 ± 7.82 ± 1.06 ± 15.59 ± 7.46 
 
Table 6:  Drug release parameters for the 
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increase core weight, but no simple 
relationship emerged between particle size 
or weight on one hand and these parameters 
on the other hand. 
 
Table 7: Calculated values of m•  t•  for 
microcapsules of varying core sizes and weights 
 




µg m•  (µg)                                 t•  (min)
0.3 2.16 1.02 52 
0.4 5.12 2.41 71 
0.5 10.0 4.7 88 
0.6 17.28 8.12 104 
0.7 27.44 12.90 123 
0.8 40.96 19.25 140 
0.9 58.32 27.41 157 
1.0 80.0 37.6 175 
1.1 106.48 50.05 192 
1.2 138.24 64.97 209 
1.3 175.76 82.61 227 
1.4 219.52 102.93 243 
 
To confirm the validity of these predictions, 
the observed and expected values of m∞, t∞ 
and slope of m versus t plot were compared 
and the data are presented in Table 8. The 
standard deviations of the observed from the 
expected results were within + 10% except in 
the case of the slope where the standard 
deviation was up to + 15%. Nevertheless, the 
analysis shows that the predictions were 
accurate with a probability of over 85%. 
 
Table 8: Comparison of the empirical (E) and 
theoretical (T) release data for single 
microcapsules at same core weights 
 
Parameters 




E T E T E T 
34 18 15.98 120 131 0.15 0.122 
94 43.5 44.2 180 184 0.24 0.24 
133 61.6 62.5 225 206 0.27 0.3 




It is concluded from the results of the study 
that the parameters which completely define 
the release profiles of the single aspirin 
crystals are the rate order of release, the 
zero and first order dissolution rate constant 
k0 and k1 respectively, the amount released, 
m1, at the end of zero order flux and the time 
to attain it t1. Others are the maximum 
release, m∞, and time to attain it, t∞. For the 
single microcapsules the parameters needed 
to define the release profiles are the Fick’s 
zero order rate order equation, the diffusion 
coefficient, D, m∞ and t∞. Of these 
parameters, the rate order equation, the 
dissolution rate constants and the membrane 
diffusion coefficients must first be 
determined experimentally. Thus by using a 
few single particles to determine these 
parameters it was possible to simulate the 
release profiles of single particles of a wide 
range of particle size distribution. The 
empirical finding that m1 and m∞ were 
constant fractions of the initial particle weight 
could be exploited to predict their values at 
Figure 9:  Simulated release profiles of single 
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different particle sizes or weights. In the 
second part of this study we shall present 
how the theoretical release data on single 
particles were used to predict the release 
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